PDF
File
Kurs & Likviditet
Kalender
| 2025-01-31 | Bokslutskommuniké 2024 |
| 2024-10-25 | Kvartalsrapport 2024-Q3 |
| 2024-07-19 | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | Ordinarie utdelning MCAP 0.00 SEK |
| 2024-05-06 | Årsstämma 2024 |
| 2024-05-03 | Kvartalsrapport 2024-Q1 |
| 2024-01-31 | Bokslutskommuniké 2023 |
| 2023-10-27 | Kvartalsrapport 2023-Q3 |
| 2023-07-28 | Kvartalsrapport 2023-Q2 |
| 2023-05-09 | Ordinarie utdelning MCAP 0.00 SEK |
| 2023-05-08 | Årsstämma 2023 |
| 2023-05-03 | Kvartalsrapport 2023-Q1 |
| 2023-02-10 | Bokslutskommuniké 2022 |
| 2022-10-28 | Kvartalsrapport 2022-Q3 |
| 2022-07-29 | Kvartalsrapport 2022-Q2 |
| 2022-05-10 | Ordinarie utdelning MCAP 0.00 SEK |
| 2022-05-09 | Årsstämma 2022 |
| 2022-05-06 | Kvartalsrapport 2022-Q1 |
| 2022-02-10 | Bokslutskommuniké 2021 |
| 2021-12-09 | Extra Bolagsstämma 2022 |
| 2021-10-29 | Kvartalsrapport 2021-Q3 |
| 2021-07-30 | Kvartalsrapport 2021-Q2 |
| 2021-05-11 | Ordinarie utdelning MCAP 0.00 SEK |
| 2021-05-10 | Årsstämma 2021 |
| 2021-05-07 | Kvartalsrapport 2021-Q1 |
| 2021-02-19 | Bokslutskommuniké 2020 |
| 2020-12-14 | Extra Bolagsstämma 2020 |
| 2020-10-30 | Kvartalsrapport 2020-Q3 |
| 2020-08-19 | Kvartalsrapport 2020-Q2 |
| 2020-05-12 | Ordinarie utdelning MCAP 0.00 SEK |
| 2020-05-11 | Årsstämma 2020 |
| 2020-05-08 | Kvartalsrapport 2020-Q1 |
| 2020-02-17 | Bokslutskommuniké 2019 |
| 2019-10-31 | Kvartalsrapport 2019-Q3 |
| 2019-08-09 | Kvartalsrapport 2019-Q2 |
| 2019-05-14 | Ordinarie utdelning MCAP 0.00 SEK |
| 2019-05-13 | Årsstämma 2019 |
| 2019-05-10 | Kvartalsrapport 2019-Q1 |
| 2019-02-15 | Bokslutskommuniké 2018 |
| 2018-11-02 | Kvartalsrapport 2018-Q3 |
| 2018-08-10 | Kvartalsrapport 2018-Q2 |
| 2018-05-22 | Ordinarie utdelning MCAP 0.00 SEK |
| 2018-05-21 | Årsstämma 2018 |
| 2018-05-11 | Kvartalsrapport 2018-Q1 |
| 2018-02-23 | Bokslutskommuniké 2017 |
| 2017-11-30 | Kvartalsrapport 2017-Q2 |
| 2017-11-06 | Extra Bolagsstämma 2017 |
| 2017-09-05 | Ordinarie utdelning MCAP 0.00 SEK |
| 2017-02-24 | Kvartalsrapport 2017-Q3 |
| 2016-10-28 | Extra Bolagsstämma 2016 |
| 2016-09-27 | Split MCAP 10:1 |
| 2016-09-05 | Ordinarie utdelning MCAP 0.00 SEK |
| 2016-09-02 | Årsstämma 2017 |
| 2016-09-02 | Kvartalsrapport 2017-Q1 |
| 2016-06-10 | Bokslutskommuniké 2016 |
| 2016-02-26 | Kvartalsrapport 2016-Q3 |
| 2015-11-30 | Kvartalsrapport 2016-Q2 |
| 2015-08-31 | Ordinarie utdelning MCAP 0.00 SEK |
| 2015-08-28 | Kvartalsrapport 2016-Q1 |
| 2015-08-28 | Årsstämma 2016 |
| 2015-06-12 | Bokslutskommuniké 2015 |
| 2015-02-20 | Kvartalsrapport 2015-Q3 |
| 2014-11-28 | Kvartalsrapport 2015-Q2 |
| 2014-09-19 | Kvartalsrapport 2015-Q1 |
| 2014-09-01 | Ordinarie utdelning MCAP 0.00 SEK |
| 2014-08-29 | Årsstämma 2015 |
| 2014-06-13 | Bokslutskommuniké 2014 |
| 2014-02-21 | Kvartalsrapport 2014-Q3 |
| 2013-11-29 | Kvartalsrapport 2014-Q2 |
| 2013-09-02 | Ordinarie utdelning MCAP 0.00 SEK |
| 2013-08-30 | Kvartalsrapport 2014-Q1 |
| 2013-06-14 | Bokslutskommuniké 2013 |
| 2013-03-13 | 15-7 2013 |
| 2013-02-22 | Kvartalsrapport 2013-Q3 |
| 2012-11-30 | Kvartalsrapport 2013-Q2 |
| 2012-09-28 | Kapitalmarknadsdag 2012 |
| 2012-09-03 | Ordinarie utdelning MCAP 0.00 SEK |
| 2012-08-31 | Årsstämma 2013 |
| 2012-08-31 | Kvartalsrapport 2013-Q1 |
| 2012-06-14 | Bokslutskommuniké 2012 |
| 2012-02-24 | Kvartalsrapport 2012-Q3 |
| 2012-01-05 | Extra Bolagsstämma 2012 |
| 2011-11-30 | Kvartalsrapport 2012-Q2 |
| 2011-08-29 | Ordinarie utdelning MCAP 0.00 SEK |
| 2011-08-26 | Kvartalsrapport 2012-Q1 |
| 2011-08-26 | Årsstämma 2012 |
| 2011-06-14 | Bokslutskommuniké 2011 |
| 2011-03-01 | Kvartalsrapport 2011-Q3 |
| 2010-11-30 | Kvartalsrapport 2010-Q3 |
| 2010-08-30 | Bonusutdelning MCAP 0 |
| 2010-08-27 | Kvartalsrapport 2010-Q2 |
| 2010-06-14 | Bokslutskommuniké 2009 |
| 2010-06-14 | Kvartalsrapport 2010-Q1 |
| 2010-03-01 | Kvartalsrapport 2009-Q3 |
| 2009-11-30 | Kvartalsrapport 2009-Q2 |
| 2009-09-02 | Kvartalsrapport 2009-Q1 |
| 2009-08-26 | Årsstämma 1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
- The Group's net sales amounted to SEK 262.8 (222.6) million, an increase of 18 percent.
- The Group's EBITDA was SEK 56.3 (40.5) million, an increase of 39 percent.
- The EBITDA margin was 21 (18) percent.
- Profit after tax amounted to SEK 19.7 (15.1) million.
- Earnings per share amounted to SEK 1.3 (0.9).
- Cash flow from operating activities was SEK 56.3 (17.3) million.
CEO's comments
Sales growth
The Group's sales increased by 18 percent in the first quarter. The Group's companies experienced good demand and both business areas showed good sales growth. In MedTech, sales increased for all companies. In Specialty Pharma, sales increased mainly in the registered pharmaceutical portfolio, but contract manufacturing also increased its sales.
Margin improvement
EBITDA increased by 39 percent. The EBITDA margin was 21 percent, an improvement of 3 percentage points. Higher volumes contributed to the increased margin. Purchasing and transport costs increased and have been partly offset by price increases. Delivery problems and long lead times are occurring for several inputs, but this has not had a significant impact on the Group as a whole.
Strong financial position and capacity for acquisitions
MedCap is a long-term owner that acquires and develops small and medium-sized life science companies that are strong in a product area or market, and have potential for continuing expansion. The Group has a strong financial position and we see good opportunities for acquisitions.
In conclusion
The horrific events in Ukraine are a humanitarian tragedy. The Group does not have any operations in Ukraine or Russia, but it is difficult to foresee what impact the invasion may have on international supply chains.
The first quarter was a good start to the year for all the Group's companies. I see good opportunities for continued positive development.
Anders Dahlberg, CEO
Stockholm, 6 May 2022
This disclosure contains information that MedCap AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 06-05-2022 06:30 CET.
Anders Dahlberg, CEO, Mobile 46 704 269 262, e-mail anders.dahlberg@medcap.se (karl.tobieson@medcap.se)